Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
71%
Breast Cancer
68%
Patient-Reported Outcome
61%
Colorectal Cancer
56%
Symptom
55%
Quality of Life
53%
Radiation Therapy
46%
Adverse Event
42%
Overall Survival
42%
Disease
36%
Clinical Trial
36%
Hazard Ratio
27%
Prostate Cancer
26%
Oncology
24%
Nicotine Withdrawal
23%
Cancer Risk
23%
Recurrent Disease
22%
Colon Cancer
22%
Proton Therapy
22%
Hereditary Nonpolyposis Colorectal Cancer
21%
Cancer Therapy
21%
Biological Marker
20%
Non Small Cell Lung Cancer
18%
Mild Cognitive Impairment
18%
Surgery
18%
Intensity Modulated Radiation Therapy
18%
Odds Ratio
18%
Arm
18%
Cancer
17%
Myeloproliferative Neoplasm
17%
Magnetic Resonance Imaging
16%
DNA Mismatch Repair
15%
Myelofibrosis
15%
Clinician
15%
Trastuzumab
14%
Stereotactic Body Radiation Therapy
14%
Body Mass Index
13%
Prevalence
13%
Drug Therapy
12%
Nonsteroid Antiinflammatory Agent
12%
Amyloid
12%
Alzheimer's Disease
12%
Placebo
12%
Nodular Melanoma
11%
Ovarian Cancer
11%
Rectum Cancer
11%
Ganglioglioma
11%
Systematic Review
11%
Diagnosis
11%
Gastrointestinal Bleeding
11%
BRCA1
10%
Cognitive Defect
10%
Smoking
10%
Mammography
10%
Health Care Cost
10%
Antiplatelet
10%
Randomized Controlled Trial
10%
Gene Mutation
9%
Lung Cancer
9%
Bupropion
9%
Prospective Study
9%
Bleeding
9%
Polycythemia vera
9%
Brachytherapy
9%
Logistic Regression Analysis
9%
Endometrial Cancer
8%
Antithrombotic
8%
Proportional Hazards Model
8%
Clinical Oncology
8%
Diabetes
8%
BRCA2
8%
Physical Activity
8%
Glioblastoma
8%
Apoplexy
8%
Stereotactic Radiosurgery
8%
Multivariate Analysis
7%
Positron Emission Tomography
7%
Drug Megadose
7%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
7%
Biopsy
7%
Family History
7%
Treatment Planning
7%
Disease Free Survival
7%
Tobacco Use
7%
Anticoagulant
7%
Progression Free Survival
7%
Mastectomy
6%
Symptom Assessment
6%
Outcome Assessment
6%
Electronic Health Record
6%
Pancreas Cancer
6%
Squamous Cell Carcinoma
6%
Positron Emission Tomography-Computed Tomography
6%
Brain Metastasis
6%
Cervical Cancer
6%
Symptom Management
6%
Estrogen Receptor
6%
Proton-Pump Inhibitor
6%
Microsatellite Instability
6%
Keyphrases
Colorectal Cancer
69%
Mild Cognitive Impairment
68%
Confidence Interval
60%
Hazard Ratio
36%
Tumor
36%
Mayo Clinic Study of Aging
34%
Overall Survival
31%
Colorectal Cancer Risk
29%
Smoking Cessation
27%
Cancer Families
26%
Alzheimer's Disease
26%
Lynch Syndrome
25%
Breast Cancer
25%
Patient-reported Outcomes
24%
Dementia
24%
Quality of Life
23%
Odds Ratio
23%
Myeloproliferative Neoplasms
23%
Family Registry
22%
CD8+ T Cells
22%
Colon Cancer
21%
Population-based Study
21%
Cancer Treatment
20%
Mutation Carriers
20%
Clinical Trials
19%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
19%
Treatment Group
18%
Trastuzumab
18%
Neuropsychiatric Symptoms
17%
Cognitively Normal
17%
High Risk
16%
Physical Activity
16%
Phase II Trial
16%
Adverse Events
16%
Radiation Therapy
16%
Apolipoprotein E
16%
Risk Factors
16%
Mayo Clinic
15%
North Central
15%
Myelofibrosis
14%
In Cancer
14%
Cancer Clinical Trials
14%
Patient-Reported Outcomes Measurement Information System (PROMIS)
14%
Older Adults
14%
Placebo
14%
Genome-wide Association Study
14%
Adjuvant Trastuzumab
14%
Breast Cancer Risk
14%
Symptom Burden
14%
Mismatch Repair Genes
13%
Amnestic Mild Cognitive Impairment (aMCI)
13%
Nicotine
12%
Ovarian Cancer
12%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Clinical Outcomes
11%
Olmsted County
11%
APOE4
11%
MLH1
11%
BRCA mutation Carriers
11%
Cognitive Impairment
11%
Breast Cancer Susceptibility Gene 1 (BRCA1)
11%
Gene mutation
10%
Population-based
10%
Gene Expression
10%
Mismatch Repair
10%
Phase II Study
10%
Chemotherapy
10%
Depressive Symptoms
10%
BRCA2 mutation
10%
Polycythemia Vera
10%
Elderly People
9%
Cancer Risk
9%
Non-carriers
9%
Body Mass Index
9%
Local Control
9%
Disease-free Survival
9%
Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events
9%
Smokers
9%
Aging
9%
Imaging Biomarkers
9%
Gastrointestinal Bleeding
9%
Essential Thrombocythemia
9%
NCCTG
9%
Ovarian Cancer Risk
9%
Quitline
9%
United States
8%
Endometrial Cancer
8%
Cancer Cases
8%
Microsatellite Instability-high (MSI-H)
8%
PMS2
8%
Randomized Controlled Trial
8%
Parkinson's Disease
8%
Tobacco Cessation
8%
Later Life
8%
Early Breast Cancer
8%
Cancer Patients
8%
Proton Pump Inhibitors
8%
Intensity-modulated Radiation Therapy
8%
BRCA1, BRCA2
8%
Oncology
8%